World Library  
Flag as Inappropriate
Email this Article

Alpha-1 blocker

Article Id: WHEBN0002605722
Reproduction Date:

Title: Alpha-1 blocker  
Author: World Heritage Encyclopedia
Language: English
Subject: Alpha blocker, Neuromodulation, Alfuzosin, Nicotinic antagonist, Doxazosin
Publisher: World Heritage Encyclopedia

Alpha-1 blocker

Alpha-1 blockers (also called alpha-adrenergic blocking agents) constitute a variety of drugs that block α1-adrenergic receptors in arteries, smooth muscles, and central nervous system tissues.


  • Pharmacology 1
  • Indications 2
  • Examples of alpha blockers 3
  • Adverse effects and interactions 4
  • References 5
  • External links 6


The blockade or reduction of epinephrine and norepinephrine binding on alpha adrenoreceptors reduce arteriolar resistance and increase venous capacitance causes a reflex increase in heart rate. Depending on plasma concentration they may cause orthostatic hypotension. Alpha-1 blockers may decrease LDL and triglycerides and increase HDL.


These drugs may be used to treat:

Examples of alpha blockers

Selective Alpha-1 blockers
Blocker Use Common Brand Name
Doxazosin[2] Hypertension and benign prostatic hyperplasia (BPH) (Cardura)
Silodosin Benign prostatic hyperplasia (Rapaflo)
Prazosin Hypertension (Minipress)
Tamsulosin Benign prostatic hyperplasia (Flomax)
Alfuzosin Benign prostatic hyperplasia (Uroxatral)
Terazosin Hypertension and BPH (Hytrin)

Others include:

Non-selective Adrenergic blockers:

Silodosin shows high affinity and selectivity for α1A adrenergic receptors found in the prostate which ensures that it works quickly and effectively to relieve the symptoms of BPH. Silodosin's low affinity for α1B receptors in the blood vessels is thought to be reflected in its low incidence of orthostatic and vasodilatory side effects.[3]

Tamsulosin is relatively selective for α1a-adrenergic receptors, which are mainly present in the prostate. Hence, it may have a more selective action in BPH with minimal effects on blood pressure.

Adverse effects and interactions

By reducing α1-adrenergic activity of the blood vessels, these drugs may cause hypotension (low blood pressure) and interrupt the baroreflex response. In doing so, they may cause dizziness, lightheadedness, or fainting when rising from a lying or sitting posture (known as orthostatic hypotension or postural hypotension). For this reason, it is generally recommended that alpha blockers should be taken at bedtime. Additionally, the risk of first dose phenomenon may be reduced by starting at a low dose and titrating upwards as needed.

Because these medications may cause orthostatic hypotension, as well as low blood pressure in general, these agents may interact with other medications that increase risk for low blood pressure, such as other antihypertensives and vasodilators.

As discussed above, tamsulosin may have less risk for low blood pressure and orthostatic hypotension due to its selectivity for α1a-adrenergic receptors. On the other hand, the drug (a) elevates risk for floppy iris syndrome, and (b) might show adverse drug reactions (ADRs) characteristic of the sulfa related drugs.


  1. ^ Höfner K (December 1999). "alpha(1)-Blocker therapy in the nineties: focus on the disease". Prostate Cancer Prostatic Dis. 2 (S4): S9–S15.  
  2. ^ Yilmaz E, Batislam E, Basar MM, Tuglu D, Ferhat M, Basar H (June 2005). "The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones". J. Urol. 173 (6): 2010–2.  
  3. ^ Nomiya M, Yamaguchi O. A quantitative analysis of mRNA expression of alpha 1 and beta-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders. J Urol. 2003;170(2 Pt 1):649-653.

External links

  • DrugDigest - Alpha blockers
  • - Tamsulosin
  • alpha-Adrenergic Blockers at the US National Library of Medicine Medical Subject Headings (MeSH)
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.